Naka Go - Department of Respiratory Medicine, National Center for Global Health and Medicine

基本信息

浏览量：14

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 58 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Whole Picture of First-Line Osimertinib for EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer: Real-World Efficacy, Safety, Progression Pattern, and Posttreatment Therapy (reiwa Study)

Kageaki Watanabe,Yukio Hosomi,Katsuhiko Naoki,Yoshiro Nakahara,Yoko Tsukita,Hirotaka Matsumoto,Kiyotaka Yoh,Yasuhito Fujisaka,Satoshi Takahashi,Saori Takata,Kazuhiro Usui,Kazuma Kishi,Go Naka, Shu Tamano,Kohei Uemura,Hideo Kunitoh

JTO Clinical and Research Reportspp.100720, (2024)

引用0浏览0WOS引用

Efficacy of First-Line Immune Checkpoint Inhibitor and Anti-Angiogenic Agent Combination Therapy for Kirsten Rat Sarcoma Viral Antigen-Mutant Advanced Non-Small-cell Lung Cancer: a Systematic Review and Network Meta-Analysis

Akinari Tsukada,Chie Morita,Yosuke Shimizu,Yukari Uemura,Go Naka,Jin Takasaki,Hiroshi Nokihara,Shinyu Izumi,Masayuki Hojo

THORACIC CANCERno. 25 (2024): 1854-1862

引用0浏览0WOS引用

Correlation of Toxicities and Efficacies of Pemetrexed with Clinical Factors and Single-Nucleotide Polymorphisms: a Prospective Observational Study

Yuichiro Takeda,Go Naka,Yuki Katsuya,Konomi Kobayashi,Manabu Suzuki,Masao Hashimoto,Satoshi Hirano,Yukari Uemura

BMC cancerno. 1 (2023)

引用0浏览0WOS引用

Clinical analysis of the efficacy of bronchial artery embolization using a gelatin sponge for the treatment of cryptogenic hemoptysis

Manabu Suzuki,Naoko Nagano,Shota Yamamoto, Satoki Hatano,Chie Morita,Akinari Tsukada,Akane Ishida,Yusaku Kusaba,Masao Hashimoto,Go Naka,Jin Takasaki, Hiroshi Nokihara,Shinyu Izumi,Masayuki Hojo,Haruhito Sugiyama

RESPIROLOGY (2023): 391-391

引用0浏览0引用

Final report on plasma ctDNA T790M monitoring during EGFR-TKI treatment in patients with EGFR mutant non-small cell lung cancer (JP-CLEAR trial)

Go Naka,Takuma Yokoyama,Kazuhiro Usui,Hiroo Ishida,Kazuma Kishi,Kohei Uemura,Yasuo Ohashi,Hideo Kunitoh

JAPANESE JOURNAL OF CLINICAL ONCOLOGY（2022）

引用2浏览0WOS引用

T790M mutation positive squamous cell carcinoma transformation from EGFR-mutated lung adenocarcinoma after low dose erlotinib: A case report and literature review

Yusaku Kusaba,Yuichiro Takeda, Sakurako Abe,Akinari Tsukada,Go Naka

MEDICINE（2022）

引用0浏览0WOS引用

A Rare Case of Docetaxel‐induced Myositis in a Patient with a Lung Adenocarcinoma

Akane Ishida, Ayumi Ushio,Masao Hashimoto,Satoru Ishii,Go Naka,Motoyasu Iikura,Shinyu Izumi,Masayuki Hojo,Haruhito Sugiyama

Thoracic cancer（2022）

引用1浏览0WOS引用

Efficacy and safety of first-line osimertinib treatment and postprogression patterns of care in patients with epidermal growth factor receptor activating mutation-positive advanced non-small cell lung cancer (Reiwa study): study protocol of a multicentre, real-world observational study

Kageaki Watanabe,Kiyotaka Yoh,Yukio Hosomi,Kazuhiro Usui,Go Naka,Kazuma Kishi,Kohei Uemura,Yasuo Ohashi,Hideo Kunitoh

BMJ OPEN（2022）

引用3浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn